- Home
- BRKL vs RXST Comparison
BRKL vs RXST Comparison
Compare BRKL & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKL
- RXST
- Stock Information
- Founded
- BRKL 1871
- RXST 1997
- Country
- BRKL United States
- RXST United States
- Employees
- BRKL N/A
- RXST N/A
- Industry
- BRKL Savings Institutions
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BRKL Finance
- RXST Health Care
- Exchange
- BRKL Nasdaq
- RXST Nasdaq
- Market Cap
- BRKL 897.3M
- RXST 1.0B
- IPO Year
- BRKL 1998
- RXST 2021
- Fundamental
- Price
- BRKL $10.24
- RXST $14.92
- Analyst Decision
- BRKL Buy
- RXST Buy
- Analyst Count
- BRKL 2
- RXST 10
- Target Price
- BRKL $15.25
- RXST $39.30
- AVG Volume (30 Days)
- BRKL 474.6K
- RXST 996.6K
- Earning Date
- BRKL 07-23-2025
- RXST 05-07-2025
- Dividend Yield
- BRKL 5.25%
- RXST N/A
- EPS Growth
- BRKL N/A
- RXST N/A
- EPS
- BRKL 0.82
- RXST N/A
- Revenue
- BRKL $338,567,000.00
- RXST $148,310,000.00
- Revenue This Year
- BRKL $53.95
- RXST $22.25
- Revenue Next Year
- BRKL $37.82
- RXST $18.58
- P/E Ratio
- BRKL $12.51
- RXST N/A
- Revenue Growth
- BRKL N/A
- RXST 46.70
- 52 Week Low
- BRKL $8.01
- RXST $12.53
- 52 Week High
- BRKL $13.15
- RXST $60.81
- Technical
- Relative Strength Index (RSI)
- BRKL 42.65
- RXST 44.77
- Support Level
- BRKL $10.14
- RXST $14.70
- Resistance Level
- BRKL $10.52
- RXST $16.36
- Average True Range (ATR)
- BRKL 0.22
- RXST 0.88
- MACD
- BRKL -0.06
- RXST 0.13
- Stochastic Oscillator
- BRKL 10.78
- RXST 48.37
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.